These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7723353)

  • 1. Cardiac refractoriness in rats is reduced by angiotensin II.
    De Mello WC; Crespo MJ
    J Cardiovasc Pharmacol; 1995 Jan; 25(1):51-6. PubMed ID: 7723353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II-1 receptors mediate both vasoconstrictor and hypertrophic responses in rat aortic smooth muscle cells.
    Chiu AT; Roscoe WA; McCall DE; Timmermans PB
    Receptor; 1991; 1(3):133-40. PubMed ID: 1843203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation.
    Virone-Oddos A; Desangle V; Provost D; Cazes M; Caussade F; Cloarec A
    Br J Pharmacol; 1997 Feb; 120(3):488-94. PubMed ID: 9031754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
    Shibouta Y; Inada Y; Ojima M; Wada T; Noda M; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K
    J Pharmacol Exp Ther; 1993 Jul; 266(1):114-20. PubMed ID: 8331552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.
    Dickinson KE; Cohen RB; Skwish S; Delaney CL; Serafino RP; Poss MA; Gu Z; Ryono DE; Moreland S; Powell JR
    Br J Pharmacol; 1994 Sep; 113(1):179-89. PubMed ID: 7812609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies.
    Wienen W; Mauz AB; Van Meel JC; Entzeroth M
    Mol Pharmacol; 1992 Jun; 41(6):1081-8. PubMed ID: 1614410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonpeptide angiotensin II receptor antagonists: insurmountable angiotensin II antagonism of EXP3892 is reversed by the surmountable antagonist DuP 753.
    Wong PC; Timmermans PB
    J Pharmacol Exp Ther; 1991 Jul; 258(1):49-57. PubMed ID: 2072311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Losartan exerts antiarrhythmic activity independent of angiotensin II receptor blockade in simulated ventricular ischemia and reperfusion.
    Thomas GP; Ferrier GR; Howlett SE
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1090-7. PubMed ID: 8819490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of captopril, losartan, and nifedipine on cell hypertrophy of cultured vascular smooth muscle from hypertensive Ren-2 transgenic rats.
    Peiró C; Llergo JL; Angulo J; López-Novoa JM; Rodríguez-López A; Rodríguez-Mañas L; Sánchez-Ferrer CF
    Br J Pharmacol; 1997 Aug; 121(7):1438-44. PubMed ID: 9257925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist.
    Robertson MJ; Barnes JC; Drew GM; Clark KL; Marshall FH; Michel A; Middlemiss D; Ross BC; Scopes D; Dowle MD
    Br J Pharmacol; 1992 Dec; 107(4):1173-80. PubMed ID: 1467838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DuP 532: a second generation of nonpeptide angiotensin II receptor antagonists.
    Chiu AT; Carini DJ; Duncia JV; Leung KH; McCall DE; Price WA; Wong PC; Smith RD; Wexler RR; Timmermans PB
    Biochem Biophys Res Commun; 1991 May; 177(1):209-17. PubMed ID: 2043107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac angiotensin receptors: effects of selective angiotensin II receptor antagonists, DUP 753 and PD 121981, in rabbit heart.
    Scott AL; Chang RS; Lotti VJ; Siegl PK
    J Pharmacol Exp Ther; 1992 Jun; 261(3):931-5. PubMed ID: 1602398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanical strain and collagen potentiate mitogenic activity of angiotensin II in rat vascular smooth muscle cells.
    Sudhir K; Wilson E; Chatterjee K; Ives HE
    J Clin Invest; 1993 Dec; 92(6):3003-7. PubMed ID: 8254054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype.
    Criscione L; de Gasparo M; Bühlmayer P; Whitebread S; Ramjoué HP; Wood J
    Br J Pharmacol; 1993 Oct; 110(2):761-71. PubMed ID: 8242249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II-mediated facilitation of sympathetic neurotransmission in the spontaneously hypertensive rat is not associated with neuronal uptake of the peptide.
    Jonsson JR; Smid SD; Frewin DB; Head RJ
    J Cardiovasc Pharmacol; 1993 Nov; 22(5):750-3. PubMed ID: 7506328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro pharmacology of L-158,809, a new highly potent and selective angiotensin II receptor antagonist.
    Chang RS; Siegl PK; Clineschmidt BV; Mantlo NB; Chakravarty PK; Greenlee WJ; Patchett AA; Lotti VJ
    J Pharmacol Exp Ther; 1992 Jul; 262(1):133-8. PubMed ID: 1625192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of various angiotensin receptor antagonists on cardiovascular responses to angiotensin II in pithed rats.
    Zhang J; Pfaffendorf M; van Zwieten PA
    J Cardiovasc Pharmacol; 1994 Jul; 24(1):108-13. PubMed ID: 7521474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2).
    Wong PC; Hart SD; Zaspel AM; Chiu AT; Ardecky RJ; Smith RD; Timmermans PB
    J Pharmacol Exp Ther; 1990 Nov; 255(2):584-92. PubMed ID: 2243344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic effects of angiotensin II and the influence of angiotensin receptor antagonists in pithed rabbits.
    Zhang J; Pfaffendorf M; van Zwieten PA
    J Cardiovasc Pharmacol; 1995 May; 25(5):724-31. PubMed ID: 7630151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AT1 receptors mediate the release of prostaglandins in porcine smooth muscle cells and rat astrocytes.
    Leung KH; Chang RS; Lotti VJ; Roscoe WA; Smith RD; Timmermans PB; Chiu AT
    Am J Hypertens; 1992 Sep; 5(9):648-56. PubMed ID: 1418854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.